Mostrar el registro sencillo del ítem

Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictivive factor

dc.contributor.authorUriol Egido, Esther 
dc.contributor.authorSierra Zapico, Marta Isabel 
dc.contributor.authorComendador García, Miguel Ángel 
dc.contributor.authorFra Rodríguez, Joaquín 
dc.contributor.authorMartínez Camblor, Pablo 
dc.contributor.authorJiménez Lacave, Ángel 
dc.contributor.authorSierra Zapico, Luisa María 
dc.date.accessioned2017-03-29T05:59:27Z
dc.date.available2017-03-29T05:59:27Z
dc.date.issued2013
dc.identifier.citationMutagenesis, 28, 1, p. 39-48 (2013); doi:10.1093/mutage/ges050
dc.identifier.issn0267-8357
dc.identifier.urihttp://hdl.handle.net/10651/41345
dc.description.sponsorshipThis work was financed by MEC (DGES) PB98/1561, FICYT PB-MED01-24 and MCYT BMC2002-00930. E.U. was supported by FICYT and UO Ph.D. grants. The Oncology Institute (Instituto Universitario de Oncología del Principado de Asturias, IUOPA) is supported by Obra Social Cajastur.
dc.format.extentp. 39-48
dc.language.isoeng
dc.relation.ispartofMutagenesis
dc.rights© The Author 2012. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84871776855&doi=10.1093%2fmutage%2fges050&partnerID=40&md5=9f8601d5a7b1ad3877a3200d6690bc40
dc.titleLong-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictivive factor
dc.typejournal article
dc.identifier.doi10.1093/mutage/ges050
dc.relation.projectIDMEC/PB98/1561
dc.relation.projectIDFICYT/PB-MED01-24
dc.relation.projectIDMCYT/BMC2002-00930
dc.relation.publisherversionhttp://dx.doi.org/10.1093/mutage/ges050


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem